Journal article icon

Journal article

Ultra-high dose rate (FLASH) radiotherapy: silver bullet or fool’s gold?

Abstract:

Radiotherapy is a cornerstone of both curative and palliative cancer care. However, radiotherapy is severely limited by radiation-induced toxicities. If these toxicities could be reduced, a greater dose of radiation could be given therefore facilitating a better tumor response. Initial pre-clinical studies have shown that irradiation at dose rates far exceeding those currently used in clinical contexts reduce radiation-induced toxicities whilst maintaining an equivalent tumor response. This i...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.3389/fonc.2019.01563

Authors


More by this author
Institution:
University of Oxford
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Sub department:
CRUK/MRC Ox Inst for Radiation Oncology
Role:
Author
ORCID:
0000-0003-3072-909X
More by this author
Institution:
University of Oxford
Department:
Oncology
Role:
Author
Publisher:
Frontiers Media Publisher's website
Journal:
Frontiers in Oncology Journal website
Volume:
9
Article number:
1563
Publication date:
2020-01-17
Acceptance date:
2019-12-24
DOI:
EISSN:
ESSN: 2234-943X
Language:
English
Keywords:
Pubs id:
pubs:1078926
UUID:
uuid:3e1d20c4-5ed8-466e-aa9a-af3af2c41f2e
Local pid:
pubs:1078926
Source identifiers:
1078926
Deposit date:
2019-12-24

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP